Yang, J., Zhao, M., Zhou, X., Yan, M., Zhao, X., & Li, F. (2025). Cost-Effectiveness of Sorafenib, Lenvatinib, and FOLFOX4 for Advanced Hepatocellular Carcinoma in China. Journal of Health Science and Medical Research, 43(4), e20251153. https://doi.org/10.31584/jhsmr.20251153